Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa

Ocular Adnexal Lymphomas are the first cause of primary ocular malignancies, and among them the most common are MALT Ocular Adnexal Lymphomas. Recently systemic immunotherapy with anti-CD20 monoclonal antibody has been investigated as first-line treatment; however, the optimal management for MALT Oc...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Biomed Res Int
Κύριοι συγγραφείς: Annibali, Ombretta, Chiodi, Francesca, Sarlo, Chiara, Cortes, Magdalena, Quaranta-Leoni, Francesco M., Quattrocchi, Carlo, Bianchi, Antonella, Bonini, Stefano, Avvisati, Giuseppe
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Hindawi Publishing Corporation 2015
Θέματα:
Clinical Study
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575717/
https://ncbi.nlm.nih.gov/pubmed/26425558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/895105
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια